News
Innovative Cellular Therapeutics Announces FDA Clearance of IND for its Dominant Negative PD-1 “Armored” Next Generation CAR-T Cell Therapy 3000 2250 Innovative Cellular Therapeutics

Innovative Cellular Therapeutics Announces FDA Clearance of IND for its Dominant Negative PD-1 “Armored” Next Generation CAR-T Cell Therapy

ROCKVILLE, Md., December 4, 2019 — Innovative Cel…

Innovative Cellular Therapeutics Announces Data at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 805 612 Innovative Cellular Therapeutics

Innovative Cellular Therapeutics Announces Data at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

ICT’s lead “armored” CAR-T program, ICTCAR014, demonstr…

Innovative Cellular Therapeutics Announces Successful Completion of Pre-IND Meeting With FDA 1366 911 Innovative Cellular Therapeutics

Innovative Cellular Therapeutics Announces Successful Completion of Pre-IND Meeting With FDA

ROCKVILLE, Md., March 19, 2019 (GLOBE NEWSWIRE) —…

Innovative Cellular Therapeutics Announces Opening of U.S. Office and Appointment of New Members 1366 912 Innovative Cellular Therapeutics

Innovative Cellular Therapeutics Announces Opening of U.S. Office and Appointment of New Members

ROCKVILLE, Md., March 06, 2019 (GLOBE NEWSWIRE) —…